Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCGN

Ocugen Inc

May 07 • 04:00PM ET

1.44

-0.01 -1.03 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX OCUL EDIT INO NVAX

| Held by: VTI XBI VXF KOMP VHT ITOT IDNA LABU MOON ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	2.80%	Shs Outstand	338.30M	Perf Week	-16.76%
Market Cap	487.46M	Forward P/E	66.45	EPS next Y	0.02	Insider Trans	0.00%	Shs Float	329.04M	Perf Month	-22.58%
Enterprise Value	488.90M	PEG	-	EPS next Q	-0.05	Inst Own	21.61%	Short Float	20.63%	Perf Quarter	8.27%
Income	-71.67M	P/S	109.30	EPS this Y	6.21%	Inst Trans	3.88%	Short Ratio	7.97	Perf Half Y	0.70%
Sales	4.46M	P/B	83.92	EPS next Y	110.04%	ROA	-118.11%	Short Interest	67.89M	Perf YTD	6.67%
Book/sh	0.02	P/C	15.30	EPS next 5Y	-	ROE	-660.00%	52W High	2.72 -47.16%	Perf Year	117.49%
Cash/sh	0.09	P/FCF	-	EPS past 3/5Y	17.64% 5.89%	ROIC	-215.58%	52W Low	0.64 125.00%	Perf 3Y	105.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	21.05% 152.94%	Gross Margin	44.48%	Volatility	6.25% 6.39%	Perf 5Y	-84.32%
Dividend TTM	-	EV/Sales	109.62	EPS Y/Y TTM	-24.67%	Oper. Margin	-1483.85%	ATR (14)	0.14	Perf 10Y	-98.55%
Dividend Ex-Date	-	Quick Ratio	1.06	Sales Y/Y TTM	-1.26%	Profit Margin	-1605.22%	RSI (14)	34.82	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	-13.69%	SMA20	-16.90%	Beta	2.28	Target Price	11.57
Payout	-	Debt/Eq	5.74	Sales Q/Q	3.51%	SMA50	-23.02%	Rel Volume	1.59	Prev Close	1.46
Employees	116	LT Debt/Eq	4.73	Earnings	May 05 BMO	SMA200	-3.18%	Avg Volume	8.52M	Price	1.44
IPO	Dec 03, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.73% 266.92%	Trades		Volume	13,568,491	Change	-1.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)